The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Reliability of the Roussel Uclaf Causality Assessment Method for assessing causality in drug‐induced liver injury†‡
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Causality assessment by expert opinion addresses the unique clinical features of a particular patient along with knowledge of the hepatotoxic potential of the suspect agent versus other causes of liver injury.122”
From AASLD practice guidance on drug, herbal, and dietary supplement–induced liver injury (2023) · cites this paper as [122]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
STATISTICAL METHODS FOR ASSESSING AGREEMENT BETWEEN TWO METHODS OF CLINICAL MEASUREMENT
Martin Bland, J., & Altman, D. (1986) · The Lancet · doi:10.1016/s0140-6736(86)90837-8 · Cited by 47,965
Research works printed but not linked: 31
- Watkins, 2006, Drug‐induced liver injury: summary of a single topic clinical research conference, HEPATOLOGY, 43, 618, 10.1002/hep.21095 · DOI · Paper page
- Navarro, 2006, Current concepts: drug‐related hepatotoxicity, N Engl J Med, 354, 731, 10.1056/NEJMra052270 · DOI · Paper page
- Abboud, 2007, Drug‐induced liver injury, Drug Saf, 30, 277, 10.2165/00002018-200730040-00001 · DOI
- Lee, 2005, Recognizing drug‐induced liver injury: current problems and possible solutions, Toxicol Pathol, 33, 155, 10.1080/01926230590522356 · DOI
- Kaplowitz, 2001, Causality assessment versus guilt‐by‐association in drug hepatotoxicity, HEPATOLOGY, 33, 308, 10.1053/jhep.2001.21083 · DOI
- Danan, 1993, Causality assessment of adverse reactions to drugs. I. A novel method based on the conclusions of international consensus meetings: application to drug‐induced liver injuries, J Clin Epidemiol, 46, 1323, 10.1016/0895-4356(93)90101-6 · DOI · Paper page
- Benichou, 1993, Causality assessment of adverse reactions to drugs. II. An original model for validation of drug causality assessment methods: case reports with positive rechallenge, J Clin Epidemiol, 46, 1331, 10.1016/0895-4356(93)90102-7 · DOI · Paper page
- Maria, 1997, Development and validation of a clinical scale for the diagnosis of drug‐induced hepatitis, HEPATOLOGY, 26, 664, 10.1002/hep.510260319 · DOI · Paper page
- Lucena, 2001, Comparison of two clinical scales for causality assessment in hepatotoxicity, HEPATOLOGY, 33, 123, 10.1053/jhep.2001.20645 · DOI · Paper page
- Stojanovski, 2007, Atomoxetine‐induced hepatitis in a child, Clin Toxicol, 45, 51, 10.1080/15563650600795644 · DOI
- Yan, 2006, Rofecoxib‐induced hepatotoxicity: a forgotten complication of the coxibs, Can J Gastroenterol, 20, 351, 10.1155/2006/356434 · DOI
- Fontana, 2005, Acute liver failure due to amoxicillin and amoxicillin/clavulanate, Dig Dis Sci, 50, 1785, 10.1007/s10620-005-2938-5 · DOI
- Cárdenas, 2006, Acute hepatitis due to Shen‐Min: a herbal product derived from Polygonum multiflorum, J Clin Gastroenterol, 40, 629, 10.1097/00004836-200608000-00014 · DOI
- Lynch, 2006, Fulminant hepatic failure associated with the use of black cohosh: a case report, Liver Transpl, 12, 989, 10.1002/lt.20778 · DOI
- Björnsson, 2007, Long‐term follow‐up of patients with mild to moderate drug‐induced liver injury, Aliment Pharmacol Ther, 26, 79, 10.1111/j.1365-2036.2007.03355.x · DOI
- Andrade, 2006, Outcome of acute idiosyncratic drug‐induced liver injury: long‐term follow‐up in a hepatotoxicity registry, HEPATOLOGY, 44, 1581, 10.1002/hep.21424 · DOI · Paper page
- Masumoto, 2003, Diagnosis of drug‐induced liver injury in Japanese patients by criteria of Consensus Meetings in Europe, Hepatol Res, 25, 1, 10.1016/S1386-6346(02)00148-1 · DOI
- Lee, 2005, Hepatic findings in long‐term clinical trials of ximelagatran, Drug Saf, 28, 351, 10.2165/00002018-200528040-00006 · DOI
- Andrade, 2004, HLA class II genotype influences the type of liver injury in drug‐induced idiosyncratic liver disease, HEPATOLOGY, 39, 1603, 10.1002/hep.20215 · DOI
- Hoofnagle, 2004, Drug‐Induced Liver Network (DILIN), HEPATOLOGY, 40, 773, 10.1002/hep.20445 · DOI
- Eliasziw, 1994, Statistical methodology for the concurrent assessment of interrater and intrarater reliability: using goniometric measurements as an example, Phys Ther, 74, 777, 10.1093/ptj/74.8.777 · DOI
- Carpenter, 2000, Bootstrap confidence intervals: when, which, what? A practical guide for medical statisticians, Stat Med, 19, 1141, 10.1002/(SICI)1097-0258(20000515)19:9<1141::AID-SIM479>3.0.CO;2-F · DOI
- Walsh, 1990, Bootstrapping: a tool for clinical research, J Clin Psychol, 46, 928, 10.1002/1097-4679(199011)46:6<928::AID-JCLP2270460638>3.0.CO;2-7 · DOI
- Donner, 1987, Sample size requirements for reliability studies, Stat Med, 6, 441, 10.1002/sim.4780060404 · DOI · Paper page
- Salaffi, 2005, Measuring functional disability in early rheumatoid arthritis: the validity, reliability and responsiveness of the Recent‐Onset Arthritis Disability (ROAD) index, Clin Exp Rheumatol, 23, S31
- Migliore Norweg, 2006, A new functional status outcome measure of dyspnea and anxiety for adults with lung disease: the dyspnea management questionnaire, J Cardiopulm Rehabil, 26, 395, 10.1097/00008483-200611000-00010 · DOI
- Cheung, 2000, The UK IBDQ—a British version of the inflammatory bowel disease questionnaire: development and validation, J Clin Epidemiol, 53, 297, 10.1016/S0895-4356(99)00152-3 · DOI
- Turner, 2007, Development, validation, and evaluation of a pediatric ulcerative colitis activity index: a prospective multicenter study, Gastroenterology, 133, 423, 10.1053/j.gastro.2007.05.029 · DOI · Paper page
- Huber, 2004, Validation and clinical significance of the Childhood Myositis Assessment Scale for assessment of muscle function in the juvenile idiopathic inflammatory myopathies, Arthritis Rheum, 50, 1595, 10.1002/art.20179 · DOI
- Isenberg, 2004, International consensus outcome measures for patients with idiopathic inflammatory myopathies. Development and initial validation of myositis activity and damage indices in patients with adult onset disease, Rheumatology, 43, 49, 10.1093/rheumatology/keg427 · DOI · Paper page
- Lachin, 2004, The role of measurement reliability in clinical trials, Clin Trials, 1, 553, 10.1191/1740774504cn057oa · DOI
Cited by
Andrade, R. J., Chalasani, N., Björnsson, E. S., Suzuki, A., Kullak-Ublick, G. A., Watkins, P. B., Devarbhavi, H., Merz, M., Lucena, M. I., Kaplowitz, N., et al. (2019) · Nature Reviews Disease Primers · doi:10.1038/s41572-019-0105-0 · Cited by 924
Self-citationACG Clinical Guideline: the diagnosis and management of idiosyncratic drug-induced liver injury
Chalasani, N. P., Hayashi, P. H., Bonkovsky, H. L., Navarro, V. J., Lee, W. M., & Fontana, R. J. (2014) · American Journal of Gastroenterology · doi:10.1038/ajg.2014.131 · Cited by 860
Self-citationDrug-Induced Liver Injury Network (DILIN) Prospective Study: Rationale, Design and Conduct
Fontana, R. J., Watkins, P. B., Bonkovsky, H. L., Chalasani, N., Davern, T., Serrano, J., & Rochon, J. (2009) · Drug Safety · doi:10.2165/00002018-200932010-00005 · Cited by 486
Self-citationACG Clinical Guideline: Diagnosis and Management of Idiosyncratic Drug-Induced Liver Injury
Chalasani, N. P., Maddur, H., Russo, M. W., Wong, R. J., Reddy, K. R., & on behalf of the Practice Parameters Committee of the American College of Gastroenterology (2021) · American Journal of Gastroenterology · doi:10.14309/ajg.0000000000001259 · Cited by 430
AASLD practice guidance on drug, herbal, and dietary supplement–induced liver injury
Fontana, R. J., Liou, I., Reuben, A., Suzuki, A., Fiel, M. I., Lee, W., & Navarro, V. (2023) · Hepatology · doi:10.1002/hep.32689 · Cited by 340
Self-citationReview article: herbal and dietary supplement hepatotoxicity
Bunchorntavakul, C., & Reddy, K. R. (2013) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.12109 · Cited by 249
A prospective nationwide study of drug-induced liver injury in Korea
Suk, K. T., Kim, D. J., Kim, C. H., Park, S. H., Yoon, J. H., Kim, Y. S., Baik, G. H., Kim, J. B., Kweon, Y. O., Kim, B. I., et al. (2012) · American Journal of Gastroenterology · doi:10.1038/ajg.2012.138 · Cited by 221
Causality assessment methods in drug induced liver injury: Strengths and weaknesses
García-Cortés, M., Stephens, C., Lucena, M. I., Fernández-Castañer, A., & Andrade, R. J. (2011) · Journal of Hepatology · doi:10.1016/j.jhep.2011.02.007 · Cited by 169
Sundaram, V., & Björnsson, E. S. (2017) · Hepatology Communications · doi:10.1002/hep4.1088 · Cited by 138
Teschke, R., & Eickhoff, A. (2015) · Frontiers in Pharmacology · doi:10.3389/fphar.2015.00072 · Cited by 132
Drug-induced liver injury: a clinical update
Ghabril, M., Chalasani, N., & Björnsson, E. (2010) · Current Opinion in Gastroenterology · doi:10.1097/mog.0b013e3283383c7c · Cited by 123
Li, Y., Phillips, E. J., Dellinger, A., Nicoletti, P., Schutte, R., Li, D., Ostrov, D. A., Fontana, R. J., Watkins, P. B., Stolz, A., et al. (2021) · Hepatology · doi:10.1002/hep.31258 · Cited by 76
Self-citationGuidelines for the diagnosis and management of herb-induced liver injury
Wang, J.-B., Zhu, Y., Bai, Z.-F., Wang, F.-S., Li, X.-H., Xiao, X.-H., & Branch Committee of Hepatobiliary Diseases and Branch Committee of Chinese Patent Medicines, C. A. O. C. M. (2018) · Chinese Journal of Integrative Medicine · doi:10.1007/s11655-018-3000-8 · Cited by 53
Systematic review on Chinese herbal medicine induced liver injury
Zhang, P., Ye, Y., Yang, X., & Jiao, Y. (2016) · Evidence-Based Complementary and Alternative Medicine · doi:10.1155/2016/3560812 · Cited by 39
Whritenour, J., Ko, M., Zong, Q., Wang, J., Tartaro, K., Schneider, P., Olson, E., Van Volkenburg, M., Serrano, J., Hayashi, P., et al. (2017) · Journal of Immunotoxicology · doi:10.1080/1547691x.2016.1254305 · Cited by 37
Self-citationNin Chau, T., Cheung, W. I., Ngan, T., Lin, J., Wing San Lee, K., Tat Poon, W., King Sun Leung, V., Mak, T., Li Tse, M., & the Hong Kong Herb-Induced Liver Injury Network (HK-HILIN) (2011) · Clinical Toxicology · doi:10.3109/15563650.2010.537662 · Cited by 23
Agreement Among Different Scales for Causality Assessment in Drug-Induced Liver Injury
Das, S., Behera, S. K., Xavier, A. S., Velupula, S., Dkhar, S. A., & Selvarajan, S. (2018) · Clinical Drug Investigation · doi:10.1007/s40261-017-0601-5 · Cited by 19
Ciricillo, J., Myer, A., Yeboah-Korang, A., Osman, A., Rahim, F., Goldfarb, D. G., Sharma, Y., Louissaint, J., Sherman, K. E., & Fontana, R. J. (2025) · American Journal of Gastroenterology · doi:10.14309/ajg.0000000000003147 · Cited by 6
Self-citation
Metadata
- Authors
- Rochon, J., Protiva, P., Seeff, L. B., Fontana, R. J., Liangpunsakul, S., Watkins, P. B., Davern, T., & McHutchison, J. G.
- Venue
- Hepatology
- Published
- 2008-10
- Volume
- 48
- Issue
- 4
- Pages
- 1175-1183
- ISSN
- 0270-9139
- Cited by
- 164
- References
- 1
- Language
- en
- Licence
- doi.wiley.com/10.1002/tdm_license_1.1 (tdm, 2526 d)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.